Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2009-04-07
2011-12-13
Chandra, Gyan (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S135100, C424S141100, C424S142100
Reexamination Certificate
active
08075885
ABSTRACT:
This invention relates to methods of treating a patient suffering from heart failure, or a patient at risk for heart failure, using a GM-CSF antagonist.
REFERENCES:
patent: 2004/0053365 (2004-03-01), Renner et al.
patent: 2005/0233992 (2005-10-01), Itescu
patent: 0499161 (1992-08-01), None
patent: 0499162 (1992-08-01), None
patent: WO 2007/092939 (2007-08-01), None
patent: WO 2007/110631 (2007-10-01), None
patent: WO 2008/052277 (2008-05-01), None
Bowie et al., 1990, Science 247: 1306-1310.
Wells, 1990, Biochemistry 29:8509-8517.
Adamopoulos, S. et al.; “Physical training reduces peripheral markers of inflammation in patients with chronic heart failure”; 2001.European Heart Journal, vol. 22, pp. 791-797.
Kawai, Chuichi; “From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death: Learning From the Past for the Future”; 1999,Circulation, vol. 99, pp. 1091-1100.
Kishimoto, Chiharu et al.; “Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress”; 2003,International Journal of Cardiology, vol. 91, pp. 173-178.
Lancaster, Jordan J. et al.; “Granulocyte—macrophage colony—stimulating factor antibody improves left ventricular function and limits maladaptive remodeling following myocardial infarction”; 2008,Journal of Cardiac Failure, vol. 14, No. 6, abstract 132, p. S42.
Maekawa, Yuichiro et al.; “Effect of Granulocyte-Macrophage Colony-Stimulating Factor Inducer on Left Ventricular Remodeling After Acute Myocardial Infarction”; 2004,Journal of the American College of Cardiology, vol. 44, No. 7, pp. 1510-1520.
Postiglione, L. et al.; “Granulocyte Macrophage-Colony Stimulating Factor receptor expression on human cardiomyocytes from end-stage heart failure patients”; 2006,European Journal of Heart Failure, vol. 8, No. 6, pp. 564-570.
Seiler, Christian et al.; “Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study”; 2001,Circulation, vol. 104, pp. 2012-2017.
Rutschow, Susanne et al.; “Myocardial proteases and matrix remodeling in inflammatory heart disease”; 2006,Cardiovascular Research, vol. 69, pp. 646-656.
Bebbington Christopher R.
Yarranton Geoffrey T.
Chandra Gyan
KaloBios Pharmaceuticals, Inc.
Kilpatrick Townsend & Stockton LLP
LandOfFree
Methods of treating heart failure using an anti-GM-CSF antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating heart failure using an anti-GM-CSF antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating heart failure using an anti-GM-CSF antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253803